Emergent Biosolutions, Inc. (NYSE: EBS) last traded at $5.08, up 5.39% on the session. The quote above updates while this page is open; the figures below are drawn from Emergent Biosolutions, Inc.’s own filings and are restated only when a new one is published.
Emergent Biosolutions, Inc. trades on NYSE under the ticker EBS. Its market capitalisation is $260.47 million.
Valuation measures for Emergent Biosolutions, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $260.47M |
|---|---|
| Enterprise value | $896.17M |
| Price / sales | 0.34 |
| Price / book | 0.76 |
| Beta | 1.13 |
Trailing-twelve-month figures tagged in Emergent Biosolutions, Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $770.20M |
|---|---|
| Net income (TTM) | -$176.80M |
| EPS (TTM) | -$3.46 |
| Operating margin | -8.57% |
| Return on equity | -51.79% |
| Cash | $139.70M |
Range and volume for EBS over the past 52 weeks.
| 52-week high | $14.06 |
|---|---|
| 52-week low | $4.36 |
| Volume | 1.27M |
| Average volume | 1.05M |
| Previous close | $4.82 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.